LabConnect News

Connect to the Latest News From the World’s Leading Central Laboratory

Find out the latest news from LabConnect, the global central laboratory that connects you to confidence through premium services that simplify clinical research processes.

GeneTx and Ultragenyx Announce Investigational New Drug (IND) Application Active for GTX-102 in Patients with Angelman Syndrome

1/15/20

SARASOTA, Fla. and NOVATO, Calif., Jan. 15, 2020 (GLOBE NEWSWIRE) -- GeneTx Biotherapeutics LLC and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare diseases, today announced...

Read More

Lilly expands half-price insulin offerings

1/15/20

Like rivals Novo and Sanofi, Lilly has introduced lower cost insulin alternatives to head off criticism of list price increases it's taken on its branded versions.

Read More